Matches in SemOpenAlex for { <https://semopenalex.org/work/W3188291659> ?p ?o ?g. }
- W3188291659 endingPage "9263" @default.
- W3188291659 startingPage "9246" @default.
- W3188291659 abstract "To reconstruct systematically hyperactive transcription factor (TF)-dependent transcription networks in squamous cell carcinomas (SCCs), a computational method (ELMER) was applied to 1293 pan-SCC patient samples, and 44 hyperactive SCC TFs were identified. As a top candidate, DLX5 exhibits a notable bifurcate re-configuration of its bivalent promoter in cancer. Specifically, DLX5 maintains a bivalent state in normal tissues; its promoter is hypermethylation, leading to DLX5 transcriptional silencing in esophageal adenocarcinoma (EAC). In stark contrast, DLX5 promoter gains active histone marks and becomes transcriptionally activated in ESCC, which is directly mediated by SOX2. Functionally, silencing of DLX5 substantially inhibits SCC viability both in vitro and in vivo. Mechanistically, DLX5 cooperates with TP63 in regulating ∼2000 enhancers and promoters, which converge on activating cancer-promoting pathways. Together, our data establish a novel and strong SCC-promoting factor and elucidate a new epigenomic mechanism - bifurcate chromatin re-configuration - during cancer development." @default.
- W3188291659 created "2021-08-16" @default.
- W3188291659 creator A5003646610 @default.
- W3188291659 creator A5004073477 @default.
- W3188291659 creator A5023997325 @default.
- W3188291659 creator A5032066368 @default.
- W3188291659 creator A5032108534 @default.
- W3188291659 creator A5038387396 @default.
- W3188291659 creator A5038747150 @default.
- W3188291659 creator A5038807158 @default.
- W3188291659 creator A5049051407 @default.
- W3188291659 creator A5051965351 @default.
- W3188291659 creator A5074840368 @default.
- W3188291659 creator A5076339922 @default.
- W3188291659 creator A5079804568 @default.
- W3188291659 creator A5081721581 @default.
- W3188291659 creator A5089477321 @default.
- W3188291659 creator A5091040124 @default.
- W3188291659 date "2021-08-09" @default.
- W3188291659 modified "2023-10-16" @default.
- W3188291659 title "Activation of bivalent factor DLX5 cooperates with master regulator TP63 to promote squamous cell carcinoma" @default.
- W3188291659 cites W1947231608 @default.
- W3188291659 cites W1968931043 @default.
- W3188291659 cites W1969341584 @default.
- W3188291659 cites W1969670934 @default.
- W3188291659 cites W1973804607 @default.
- W3188291659 cites W1974043282 @default.
- W3188291659 cites W1984562049 @default.
- W3188291659 cites W1986241711 @default.
- W3188291659 cites W2006171472 @default.
- W3188291659 cites W2010382424 @default.
- W3188291659 cites W2018947009 @default.
- W3188291659 cites W2020534880 @default.
- W3188291659 cites W2022140142 @default.
- W3188291659 cites W2025183726 @default.
- W3188291659 cites W2027544745 @default.
- W3188291659 cites W2039053594 @default.
- W3188291659 cites W2041103068 @default.
- W3188291659 cites W2042087070 @default.
- W3188291659 cites W2052524459 @default.
- W3188291659 cites W2054823635 @default.
- W3188291659 cites W2076154138 @default.
- W3188291659 cites W2078455244 @default.
- W3188291659 cites W2080324830 @default.
- W3188291659 cites W2080849609 @default.
- W3188291659 cites W2095416597 @default.
- W3188291659 cites W2097626332 @default.
- W3188291659 cites W2107575419 @default.
- W3188291659 cites W2111511846 @default.
- W3188291659 cites W2119293400 @default.
- W3188291659 cites W2122953117 @default.
- W3188291659 cites W2127114672 @default.
- W3188291659 cites W2130410032 @default.
- W3188291659 cites W2131050852 @default.
- W3188291659 cites W2139025111 @default.
- W3188291659 cites W2139347946 @default.
- W3188291659 cites W2142290104 @default.
- W3188291659 cites W2146449844 @default.
- W3188291659 cites W2155270270 @default.
- W3188291659 cites W2163327652 @default.
- W3188291659 cites W2170210082 @default.
- W3188291659 cites W2171808845 @default.
- W3188291659 cites W2259938310 @default.
- W3188291659 cites W2269026928 @default.
- W3188291659 cites W2275877493 @default.
- W3188291659 cites W2341539131 @default.
- W3188291659 cites W2346530374 @default.
- W3188291659 cites W2570401594 @default.
- W3188291659 cites W2575837388 @default.
- W3188291659 cites W2753687033 @default.
- W3188291659 cites W2756360505 @default.
- W3188291659 cites W2763670669 @default.
- W3188291659 cites W2766463108 @default.
- W3188291659 cites W2784110428 @default.
- W3188291659 cites W2795903481 @default.
- W3188291659 cites W2807581530 @default.
- W3188291659 cites W2889051002 @default.
- W3188291659 cites W2889646458 @default.
- W3188291659 cites W2892002828 @default.
- W3188291659 cites W2898215009 @default.
- W3188291659 cites W2898336517 @default.
- W3188291659 cites W2902981003 @default.
- W3188291659 cites W2903411163 @default.
- W3188291659 cites W2911617279 @default.
- W3188291659 cites W2968336221 @default.
- W3188291659 doi "https://doi.org/10.1093/nar/gkab679" @default.
- W3188291659 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8450110" @default.
- W3188291659 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34370013" @default.
- W3188291659 hasPublicationYear "2021" @default.
- W3188291659 type Work @default.
- W3188291659 sameAs 3188291659 @default.
- W3188291659 citedByCount "9" @default.
- W3188291659 countsByYear W31882916592022 @default.
- W3188291659 countsByYear W31882916592023 @default.
- W3188291659 crossrefType "journal-article" @default.
- W3188291659 hasAuthorship W3188291659A5003646610 @default.
- W3188291659 hasAuthorship W3188291659A5004073477 @default.
- W3188291659 hasAuthorship W3188291659A5023997325 @default.